Crossject
Develops emergency medications delivered via a needle-free auto-injector platform.
ALCJ | PA
Overview
Corporate Details
- ISIN(s):
- FR0004178614 (+6 more)
- LEI:
- 969500W1VTFNL2D85A65
- Country:
- France
- Address:
- 6 Rue Pauline Kergomard, 21000 dijon
- Website:
- https://www.crossject.com/en
- Sector:
- Manufacturing
Description
Crossject is a specialty pharmaceutical company focused on developing and commercializing medications for life-threatening emergency situations. The company's core technology is ZENEO®, a proprietary, pre-filled, single-use needle-free auto-injector. This platform is designed to enable patients or untrained caregivers to rapidly, safely, and reliably administer emergency treatments. Crossject's product pipeline targets critical conditions such as epileptic seizures, acute adrenal crisis, and severe allergic reactions (anaphylaxis), aiming to improve patient outcomes by simplifying drug delivery in urgent scenarios.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-28 07:30 |
Crossject annonce l’initiation de la couverture de son titre par ODDO BHF
|
French | 228.6 KB | ||
| 2023-11-28 07:30 |
Crossject announces initiation of coverage by ODDO BHF
|
English | 180.5 KB | ||
| 2023-11-14 17:35 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 173.2 KB | ||
| 2023-10-05 08:45 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 186.2 KB | ||
| 2023-09-26 17:35 |
Crossject présente ses résultats financiers et faits marquants du premier semes…
|
French | 240.2 KB | ||
| 2023-09-26 17:35 |
Crossject reports financial results and business highlights for first half of 2…
|
English | 253.2 KB | ||
| 2023-09-11 17:35 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 96.0 KB | ||
| 2023-09-11 07:30 |
Crossject announces significant improvement in Gaïa ESG rating
|
English | 209.4 KB | ||
| 2023-09-11 07:30 |
Crossject annonce une nouvelle nette amélioration de sa notation ESG Gaïa
|
French | 221.0 KB | ||
| 2023-09-05 07:30 |
Crossject annonce avoir passé avec succès des audits européens et américain pou…
|
French | 249.4 KB | ||
| 2023-09-05 07:30 |
Crossject reports successful completion of European and U.S. audits for manufac…
|
English | 231.5 KB | ||
| 2023-08-08 17:49 |
Crossject : Information relative au nombre total de droits de vote et d'actions…
|
French | 177.8 KB | ||
| 2023-07-24 18:00 |
Crossject : Information relative au nombre total de droits de vote et d''action…
|
French | 162.8 KB | ||
| 2023-07-20 07:30 |
Crossject signs new licensing agreement on ZENEO® Midazolam epilepsy rescue the…
|
English | 206.3 KB | ||
| 2023-07-20 07:30 |
Crossject signe un nouvel accord de licence pour le traitement dans la crise d'…
|
French | 233.2 KB |
Automate Your Workflow. Get a real-time feed of all Crossject filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Crossject
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Crossject via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-06-24 | N/A | Other | Buy | 20,000 | N/A |
| 2024-06-14 | N/A | Other | Other | 10,979 | 20,289.19 EUR |
| 2024-06-06 | N/A | Other | Other | 1,058,617 | 1,956,324.22 EUR |
| 2024-06-06 | N/A | Other | Other | 16,106 | 29,763.89 EUR |
| 2024-06-06 | N/A | Other | Other | 10,275 | 18,988.20 EUR |
| 2024-06-06 | N/A | Other | Other | 10,074 | 18,616.75 EUR |
| 2024-06-06 | N/A | Other | Buy | 5,536 | 10,230.53 EUR |
| 2023-03-06 | N/A | Other | Other | 22,859 | 75,434.70 EUR |
Peer Companies
